Urologic manifestations of erdheim-chester disease

Daniel A. Yelfimov, Deborah J. Lightner, Matthew K. Tollefson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objective To describe the urologic manifestations of Erdheim-Chester disease (ECD). ECD is a rare multisystem disorder of non-Langerhans cell histiocytosis. In addition to classic long bone involvement, the retroperitoneum is a well-established site of disease infiltration. Herein, we present the urologic manifestations and outcomes of ECD in a large series of patients. Methods We identified 47 patients diagnosed with ECD between 1996 and 2012 at our institution. The medical records and imaging for these patients were reviewed for urologic involvement, including perirenal soft tissue encasement, renal atrophy, hydronephrosis, chronic renal insufficiency, diabetes insipidus, and lower urinary tract symptoms. Results At diagnosis, the median patient age was 57 years (interquartile range 49, 68), and median follow-up after diagnosis was 3 years (interquartile range 1.8, 7.3). There were 31 male patients (66%) and 16 female patients (34%). The majority of these patients (37, 79%) demonstrated evidence of urologic involvement from ECD, requiring urologic surgery in 13 (28%). This urologic involvement included retroperitoneal infiltration (28, 60%), worsening lower tract urinary symptoms from diabetes insipidus (21, 45%), hydronephrosis (10, 21%), and chronic kidney disease (18, 38%). Conclusion The incidence of urologic involvement with ECD is higher than previously reported in the published data. Urologists should be aware of this disorder, as it might mimic other retroperitoneal diseases and might contribute to lower urinary tract symptoms, hydronephrosis, renal atrophy, and chronic kidney disease.

Original languageEnglish (US)
Pages (from-to)218-221
Number of pages4
JournalUrology
Volume84
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Erdheim-Chester Disease
Lower Urinary Tract Symptoms
Hydronephrosis
Chronic Renal Insufficiency
Diabetes Insipidus
Atrophy
Non-Langerhans-Cell Histiocytosis
Kidney
Diagnostic Imaging
Medical Records
Bone and Bones
Incidence

ASJC Scopus subject areas

  • Urology

Cite this

Yelfimov, D. A., Lightner, D. J., & Tollefson, M. K. (2014). Urologic manifestations of erdheim-chester disease. Urology, 84(1), 218-221. https://doi.org/10.1016/j.urology.2013.10.023

Urologic manifestations of erdheim-chester disease. / Yelfimov, Daniel A.; Lightner, Deborah J.; Tollefson, Matthew K.

In: Urology, Vol. 84, No. 1, 2014, p. 218-221.

Research output: Contribution to journalArticle

Yelfimov, DA, Lightner, DJ & Tollefson, MK 2014, 'Urologic manifestations of erdheim-chester disease', Urology, vol. 84, no. 1, pp. 218-221. https://doi.org/10.1016/j.urology.2013.10.023
Yelfimov, Daniel A. ; Lightner, Deborah J. ; Tollefson, Matthew K. / Urologic manifestations of erdheim-chester disease. In: Urology. 2014 ; Vol. 84, No. 1. pp. 218-221.
@article{2f45dbd2b6ff4c2592df5b8334cccb4b,
title = "Urologic manifestations of erdheim-chester disease",
abstract = "Objective To describe the urologic manifestations of Erdheim-Chester disease (ECD). ECD is a rare multisystem disorder of non-Langerhans cell histiocytosis. In addition to classic long bone involvement, the retroperitoneum is a well-established site of disease infiltration. Herein, we present the urologic manifestations and outcomes of ECD in a large series of patients. Methods We identified 47 patients diagnosed with ECD between 1996 and 2012 at our institution. The medical records and imaging for these patients were reviewed for urologic involvement, including perirenal soft tissue encasement, renal atrophy, hydronephrosis, chronic renal insufficiency, diabetes insipidus, and lower urinary tract symptoms. Results At diagnosis, the median patient age was 57 years (interquartile range 49, 68), and median follow-up after diagnosis was 3 years (interquartile range 1.8, 7.3). There were 31 male patients (66{\%}) and 16 female patients (34{\%}). The majority of these patients (37, 79{\%}) demonstrated evidence of urologic involvement from ECD, requiring urologic surgery in 13 (28{\%}). This urologic involvement included retroperitoneal infiltration (28, 60{\%}), worsening lower tract urinary symptoms from diabetes insipidus (21, 45{\%}), hydronephrosis (10, 21{\%}), and chronic kidney disease (18, 38{\%}). Conclusion The incidence of urologic involvement with ECD is higher than previously reported in the published data. Urologists should be aware of this disorder, as it might mimic other retroperitoneal diseases and might contribute to lower urinary tract symptoms, hydronephrosis, renal atrophy, and chronic kidney disease.",
author = "Yelfimov, {Daniel A.} and Lightner, {Deborah J.} and Tollefson, {Matthew K.}",
year = "2014",
doi = "10.1016/j.urology.2013.10.023",
language = "English (US)",
volume = "84",
pages = "218--221",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Urologic manifestations of erdheim-chester disease

AU - Yelfimov, Daniel A.

AU - Lightner, Deborah J.

AU - Tollefson, Matthew K.

PY - 2014

Y1 - 2014

N2 - Objective To describe the urologic manifestations of Erdheim-Chester disease (ECD). ECD is a rare multisystem disorder of non-Langerhans cell histiocytosis. In addition to classic long bone involvement, the retroperitoneum is a well-established site of disease infiltration. Herein, we present the urologic manifestations and outcomes of ECD in a large series of patients. Methods We identified 47 patients diagnosed with ECD between 1996 and 2012 at our institution. The medical records and imaging for these patients were reviewed for urologic involvement, including perirenal soft tissue encasement, renal atrophy, hydronephrosis, chronic renal insufficiency, diabetes insipidus, and lower urinary tract symptoms. Results At diagnosis, the median patient age was 57 years (interquartile range 49, 68), and median follow-up after diagnosis was 3 years (interquartile range 1.8, 7.3). There were 31 male patients (66%) and 16 female patients (34%). The majority of these patients (37, 79%) demonstrated evidence of urologic involvement from ECD, requiring urologic surgery in 13 (28%). This urologic involvement included retroperitoneal infiltration (28, 60%), worsening lower tract urinary symptoms from diabetes insipidus (21, 45%), hydronephrosis (10, 21%), and chronic kidney disease (18, 38%). Conclusion The incidence of urologic involvement with ECD is higher than previously reported in the published data. Urologists should be aware of this disorder, as it might mimic other retroperitoneal diseases and might contribute to lower urinary tract symptoms, hydronephrosis, renal atrophy, and chronic kidney disease.

AB - Objective To describe the urologic manifestations of Erdheim-Chester disease (ECD). ECD is a rare multisystem disorder of non-Langerhans cell histiocytosis. In addition to classic long bone involvement, the retroperitoneum is a well-established site of disease infiltration. Herein, we present the urologic manifestations and outcomes of ECD in a large series of patients. Methods We identified 47 patients diagnosed with ECD between 1996 and 2012 at our institution. The medical records and imaging for these patients were reviewed for urologic involvement, including perirenal soft tissue encasement, renal atrophy, hydronephrosis, chronic renal insufficiency, diabetes insipidus, and lower urinary tract symptoms. Results At diagnosis, the median patient age was 57 years (interquartile range 49, 68), and median follow-up after diagnosis was 3 years (interquartile range 1.8, 7.3). There were 31 male patients (66%) and 16 female patients (34%). The majority of these patients (37, 79%) demonstrated evidence of urologic involvement from ECD, requiring urologic surgery in 13 (28%). This urologic involvement included retroperitoneal infiltration (28, 60%), worsening lower tract urinary symptoms from diabetes insipidus (21, 45%), hydronephrosis (10, 21%), and chronic kidney disease (18, 38%). Conclusion The incidence of urologic involvement with ECD is higher than previously reported in the published data. Urologists should be aware of this disorder, as it might mimic other retroperitoneal diseases and might contribute to lower urinary tract symptoms, hydronephrosis, renal atrophy, and chronic kidney disease.

UR - http://www.scopus.com/inward/record.url?scp=84903719947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903719947&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2013.10.023

DO - 10.1016/j.urology.2013.10.023

M3 - Article

C2 - 24788188

AN - SCOPUS:84903719947

VL - 84

SP - 218

EP - 221

JO - Urology

JF - Urology

SN - 0090-4295

IS - 1

ER -